- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02728297
Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis
April 4, 2016 updated by: Sameh Emile, Mansoura University
Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis; a Pilot Study
Evaluation of staged endoscopic thoracoscopic sympathicotomy in treatment of palmo-axillo-plantar hyperhidrosis
Study Overview
Detailed Description
This is a pilot study that investigates the efficacy of video-assisted endoscopic sympathicotomy from the level of T3 to T12 on combined palmar and plantar hyperhidrosis.
Ablation of ascending sympathetic fibers would help alleviating both types of hyperhidrosis in a single setting.
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Dakahlia
-
Mansoura, Dakahlia, Egypt
- Mansoura University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 75 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with combined palmo-axillo-plantar hyperhidrosis of ASA grade I and II
Exclusion Criteria:
- Patients under 16 years.
- Patients with bradycardia (heart rate <80 beats per minute).
- Patients with concomitant lung pathology, frozen mediastinum, pleural effusion, or history of intercostal tube insertion.
- Patients with cardiac problems with ejection fraction less than 60%.
- Patient suffering from isolated palmo-axillary hyperhidrosis not associated with plantar hyperhidrosis.
- Patients suffering from craniofacial hyperhidrosis, either isolated or combined with other areas of hyperhidrosis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Staged ETS
Video-assisted endoscopic sympathicotomy from level of T3 to level of T12 on one side
|
Thoracoscopic approach of sympathetic ganglia T3-T12 on one side, retraction of the diaphragm and lung laterally to expose the ganglia then ablation of each ganglion using electrocauterization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in severity of hyperhidrosis on visual analogue scale at 24 months
Time Frame: 24 months
|
decrease in the severity of hyperhidrosis, both palmar and plantar, according to visual analogue scale
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sameh H Emile, M.D, Mansoura University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
March 27, 2016
First Submitted That Met QC Criteria
April 4, 2016
First Posted (Estimate)
April 5, 2016
Study Record Updates
Last Update Posted (Estimate)
April 5, 2016
Last Update Submitted That Met QC Criteria
April 4, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- mansoura32
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperhidrosis
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
miraDry, Inc.Withdrawn
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
Northwestern UniversityCompletedAxillary HyperhidrosisUnited States
-
Ulthera, IncCompletedAxillary HyperhidrosisGermany
-
Peking University People's HospitalBeijing Municipal Science & Technology CommissionCompleted
-
United States Naval Medical Center, San DiegoCandela Corp.Unknown
-
Tmaer Youssef MohamedCompletedPalmar Hyperhidrosis
-
Atacama TherapeuticsCompletedPalmar HyperhidrosisUnited States
-
Miramar LabsCompletedAxillary HyperhidrosisCanada
Clinical Trials on Staged ETS
-
Karolinska InstitutetHanoi Medical UniversityUnknownHuman Immunodeficiency Virus (HIV)Vietnam
-
Seoul National University HospitalCompletedOne-lung VentilationKorea, Republic of
-
Xiamen Cardiovascular Hospital, Xiamen UniversityRecruitingPercutaneous Coronary Intervention | STEMI | Multi Vessel Coronary Artery DiseaseChina
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedTobacco Smoke PollutionUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Unknown
-
Southwest Hospital, ChinaChinese PLA General Hospital; Tongji Hospital; Second Affiliated Hospital, School... and other collaboratorsUnknownHepatolithiasisChina
-
Gangnam Severance HospitalCompletedBilateral Total Knee Chronic Pain Following Arthroplasty
-
University of ArkansasTerminated
-
Chonnam National University HospitalActive, not recruitingMyocardial Infarction, Acute | Multi-Vessel Coronary Artery StenosisKorea, Republic of
-
AtriCure, Inc.CompletedAtrial FibrillationUnited States, Netherlands, Belgium